Commercial update | 26-Aug-2025 | 07:00 | RNS |
ValiRx Awarded Grant from Open University | 07-Aug-2025 | 10:51 | RNS |
Update on Evaluation Agreement with Stingray Bio | 05-Aug-2025 | 09:53 | RNS |
Licensing Agreement with Dominion Biotech Ltd | 04-Aug-2025 | 07:00 | RNS |
Collaboration Agreement with Voxcell BioInnovation | 29-Jul-2025 | 07:00 | RNS |
Result of AGM | 30-Jun-2025 | 15:48 | RNS |
Ambrose Exercise Option on VAL401 | 20-Jun-2025 | 07:00 | RNS |
ValiRx Investor Webinar | 09-Jun-2025 | 10:57 | RNS |
Holding(s) in Company | 06-Jun-2025 | 10:54 | RNS |
Final Results & Notice of AGM | 06-Jun-2025 | 07:00 | RNS |
New Evaluation and Material Transfer Agreement | 03-Jun-2025 | 07:00 | RNS |
Holding(s) in Company | 20-May-2025 | 13:25 | RNS |
Inaphaea Deal Extension With Dominion | 12-May-2025 | 07:00 | RNS |
Commercial Update | 30-Apr-2025 | 07:00 | RNS |
Termination of Letter of Intent with TheoremRx | 03-Apr-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.58p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.35p |
52 Week Low | 0.42p |
Volume | 866,714 |
Shares Issued | 374.35m |
Market Cap | £2.15m |
RiskGrade | 435 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:42 | 18,199 @ 0.57p |
15:21 | 16,000 @ 0.63p |
15:10 | 215 @ 0.65p |
15:02 | 5,000 @ 0.65p |
13:04 | 384,107 @ 0.65p |
You are here: research